Details of the Drug Reposition

General Information of This Drug (ID: DMVB9XC)

Drug Name
Tanomastat   DMVB9XC
Synonyms Tanomastat (USAN/INN); (2S)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pancreatic cancer DISJC981 2C10 Discontinued in Phase 3 [1]
Lung cancer DISCM4YA 2C25.0 Discontinued in Phase 3 [1]
Ovarian cancer DISZJHAP 2C73 Discontinued in Phase 3 [1]
Osteoarthritis DIS05URM FA00-FA05 Discontinued in Phase 3 [1]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6468).